Compare EHang Holdings Ltd - ADR (EH) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EHang Holdings Ltd - ADR vs Inovio Pharmaceuticals Inc — how do they compare? EHang Holdings Ltd - ADR trades at $5.4 (market cap $414.87M), while Inovio Pharmaceuticals Inc trades at $1.14 (market cap $96.26M). The key difference: EHang Holdings Ltd - ADR is far larger — about 4.3× Inovio Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| EH | INO | |
|---|---|---|
Market Cap | $414.87M | $96.26M |
Sector | Industrials | Health |
52-Week High | $19.99 | $2.87 |
52-Week Low | $5.41 | $1.05 |
Enterprise Value | $354.54M | $67.27M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EHang Holdings (EH) trades at $5.41, down 0.73% on the day, with technical indicators showing bearish momentum and mixed sentiment. The company reported Q1 2026 revenue of $418 million, flat year-over-year but sharply lower than the prior quarter due to delivery timing. Despite a strong gross margin of 61.53%, the company continues to post significant net losses (-$276 million in 2025) with negative ROE and ROA. Recent news highlights both operational progress in eVTOL certification and a $30 million share repurchase program announced in June 2026.
The outlook remains challenging with persistent losses and high cash burn, though analyst consensus suggests modest upside to the $6.97 price target. Key risks include execution on commercialization, competitive pressures in the air mobility sector, and reliance on financing activities to fund operations. The stock presents speculative appeal for investors betting on long-term eVTOL adoption, but requires careful risk management given the current financial profile.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About EHang Holdings Ltd - ADR
EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
